Patent

SpicyIP Tidbit: Supreme court stays Delhi High court injunction restraining Glenmark


In a rather interesting turn of events the Supreme Court bench of Justices Ranjan Gogoi and          NV Ramana have stayed the Delhi High court order restraining Glenmark from selling Sitagliptin. We had analyzed the Delhi High court injunction order restraining Glenmark in detail over here.

Image from here

According to livemint, Merck, resisted the stay of the high court order. However the apex court said that since there had been no stay for a long time, a few more weeks would not affect anything.

The next hearing is set for 28 April.

Watch this space for more!

Hat tip: Thanks to our ever enthusiastic readers BPK and Abhimanyu for bringing this to our attention.

Madhulika Vishwanathan

Madhulika Vishwanathan

Madhulika is a registered Indian patent agent and has completed her Master’s in Pharmacology from the Institute of Chemical Technology (ICT), Mumbai. Her interests include issues involving pharmaceutical and biotechnology patent law, regulatory aspects like Hatch Waxman litigation and antitrust law.She is currently working at law firm based out of Memphis, TN.

2 comments.

  1. Kuldeep

    As the stay is not is place, is there a chance that Glenmark pumps in more batches of generic product to its distributors in India?

    Currently district court has allowed Glenmark to complete its inventory but not to sale new stock apart from the old inventory with the distributors in India.

    As the case would be taken up by Supreme court on 28th April, it would be interesting to see if Glenmark takes the opportunity and stock the Indian distributors with more and more of its generic product.

    Its just a thought that came to my mind….

    Reply

Leave a Reply

Your email address will not be published.